Kevin is a Partner in the Firm’s Corporate department. He advises on corporate finance and M&A transactions with a particular focus on private equity. As head of the Firm's Private Equity Group he has established a strong reputation for advising management and investee companies as well as equity finance providers.

His experience covers a wide range of sectors, including life sciences, education, natural resources, pharmaceuticals, media, telecoms, retail and financial services. Recent examples include acting for Russian supercar manufacturer, MaRussia Motors, on it's acquisition from Lloyd's TSB Development Capital Limited of a majority stake in Manor Holdco Limited, the Virgin Racing Formula 1 team, advising the majority shareholder of Central Asia Petroleum Ltd in relation to the US$3.3 billion disposal of JSC MangistauMunaiGaz; and advising Quotient Bioscience Group on its £35 million fundraising from US private equity house TA Associates Inc. and on the subsequent acquisition of Amersham Radiolabelling Services, the radiochemical custom synthesis operation of GE Healthcare.

Kevin is also a Notary Public and on the Legal Committee of the Quoted Companies Alliance.

Key Experience

Advised the sellers of Beatthatquote.com Limited on its disposal to Google Inc. for a sum of $61.5 million .

Advised Russian supercar manufacturer, MaRussia Motors, on it's acquisition from Lloyd's TSB Development Capital Limited of a majority stake in Manor Holdco Limited, the Virgin Racing Formula 1 team.

Advised management-backed CKH Limited on its acquisition of Devitt Insurance Services Limited from RBS Insurance Group Limited.

Advised the majority shareholder of Central Asia Petroleum Ltd, the holding company of Kazakhstan's largest privately-owned oil company, JSC MangistauMunaiGaz in relation to the US$3.3 billion disposal of a 100% stake in MMG to Mangistau Investments - a joint venture between China National Petroleum Corporation and KazMunaiGas.

Advised Quotient Bioscience Group on its £35 million fundraising from US private equity house TA Associates Inc. and its subsequent acquisition of:

Amersham Radiolabelling Services, the radiochemical custom synthesis operations of GE Healthcare; and

the Phase 1 Clinical Trials business of Charles River Clinical Services Edinburgh Limited;

Advised Young Associates Limited, a UK based private equity house, in relation to the disposal of its interests in portfolio company, Eurotel Holdings, to Inflexion Private Equity.

Advised the exiting management of Advanced Power AG in connection with 3i Group plc's investment in the company.

Advised the management team, backed by Credit Suisse, on the management buy-in of Park Finance Holdings Limited and subsequent equity restructuring.

Career History